Piyush Jindal - 06 Nov 2023 Form 4 Insider Report for LifeMD, Inc. (LFMD)

Reporting relationship: Director
Issuer ticker: LFMD
Reported as of: 06 Nov 2023
Net transaction value: +$94,500
SEC form: 4
Accepted by SEC: 08 Nov 2023, 11:23:44 UTC
Prior SEC filing: 15 Jun 2023
Next SEC filing: 19 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Piyush Jindal

Key filing fact

Piyush Jindal filed Form 4 for LifeMD, Inc. (LFMD) on 08 Nov 2023.

Key facts

This page summarizes Piyush Jindal's Form 4 filing for LifeMD, Inc. (LFMD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Nov 2023, 11:23.

Change

Previous filing in this sequence was filed on 15 Jun 2023.
Current net transaction value: +$94,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFMD transaction

Common Stock

Options Exercise

Transaction value: $94,500
Shares: +37,500
Change %: +12%
Price: $2.52
Shares after: 337,500
Date: 06 Nov 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LFMD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -37,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,500
Exercise price: $2.52
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vested in four equal installments at 90, 180, 270 and 365 days from September 14, 2022, the date of grant. The option expires on September 14, 2027.